Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
Axicabtagene ciloleucel car+ (HCPCS Q204100) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved June 30, 2026 , from http://ppman.hank.ai/transparency/procedure/Q204100/by-state?code_type=HCPCS
“Axicabtagene ciloleucel car+ (HCPCS Q204100) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/Q204100/by-state?code_type=HCPCS. Accessed
June 30, 2026 .
“Axicabtagene ciloleucel car+ (HCPCS Q204100) by State,” HANK Price Transparency ,
accessed June 30, 2026 ,
http://ppman.hank.ai/transparency/procedure/Q204100/by-state?code_type=HCPCS.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
HCPCS · across United States
Q204100 — Axicabtagene Ciloleucel Car+
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$713,138
National median
$713,138 – $1,525,264
IQR (p25 – p75)
4
hospitals filing
2
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for Q204100 (HCPCS), with interquartile range
State Median p25 p75
NV $1,795,973 $1,795,973 $1,795,973
NY $713,138 $713,138 $713,138